Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT)

Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional... Abstract Introduction Right-lateralized cardiac substructures can be substantially exposed during right breast cancer (R-BC) radiotherapy. The cardiac benefit of deep inspiration breath hold (DIBH) is established in combination with volumetric modulated arctherapy (VMAT) for left breast cancer with regional node irradiation but is unknown for R-BC. This study evaluated the dosimetric benefit of DIBH for locoregional irradiation of R-BC with VMAT. Material and Methods All patients treated for R-BC with adjuvant locoregional DIBH-VMAT in the Department of Radiation Oncology of the Institut Curie (Paris, France) until December 2022 were included, corresponding to 15 patients. FB- and DIBH-VMAT plans were compared both for a normofractionated regimen (50 Gy/25fx) used for treatment and a replanned hypofractionated regimen (40 Gy/15fx). Dose to the heart, cardiac substructures (sinoatrial node (SAN), atrio-ventricular node (AVN), right coronary artery, left anterior descending coronary artery, left ventricle), ipsilateral lung and liver were retrieved and compared. Results Mean heart dose (MHD) was 3.33 Gy with FB vs. 3.10 Gy with DIBH on normofractionated plans (p = 0.489), and 2.58 Gy with FB vs. 2.41 Gy with DIBH on hypofractionated plan (p = 0.489). The benefit of DIBH was not significant for any cardiac substructure. The most exposed cardiac substructure were the SAN (mean dose of 6.62 Gy for FB- and 5.64 Gy for DIBH-VMAT on normofractionated plans) and the RCA (mean dose of 4.21 Gy for FB- and 4.06 Gy for DIBH-VMAT on normofractionated plans). The maximum benefit was observed for the RCA with a median individual dose reduction of 0.84 Gy on normofractionated plans (p = 0.599). No significant dosimetric difference were observed for right lung. Liver mean dose was significantly lower with DIBH with median values decreasing from 2.54 Gy to 0.87 Gy (p = 0.01). Conclusion Adding DIBH to efficient cardiac-sparing radiotherapy techniques, such as VMAT, is not justified in the general case for locoregional R-BC irradiation. Specific R-BC patient subpopulations who could benefit from additional DIBH combination with locoregional VMAT are yet to be identified. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Oncologica Taylor & Francis

Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT)

Download PDF
9 pages

Loading next page...
 
/lp/taylor-francis/dosimetric-evaluation-of-the-benefit-of-deep-inspiration-breath-hold-Hbs7BmE8d8

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Taylor & Francis
Copyright
© 2023 Acta Oncologica Foundation
ISSN
1651-226X
eISSN
0284-186X
DOI
10.1080/0284186X.2023.2177976
Publisher site
See Article on Publisher Site

Abstract

Abstract Introduction Right-lateralized cardiac substructures can be substantially exposed during right breast cancer (R-BC) radiotherapy. The cardiac benefit of deep inspiration breath hold (DIBH) is established in combination with volumetric modulated arctherapy (VMAT) for left breast cancer with regional node irradiation but is unknown for R-BC. This study evaluated the dosimetric benefit of DIBH for locoregional irradiation of R-BC with VMAT. Material and Methods All patients treated for R-BC with adjuvant locoregional DIBH-VMAT in the Department of Radiation Oncology of the Institut Curie (Paris, France) until December 2022 were included, corresponding to 15 patients. FB- and DIBH-VMAT plans were compared both for a normofractionated regimen (50 Gy/25fx) used for treatment and a replanned hypofractionated regimen (40 Gy/15fx). Dose to the heart, cardiac substructures (sinoatrial node (SAN), atrio-ventricular node (AVN), right coronary artery, left anterior descending coronary artery, left ventricle), ipsilateral lung and liver were retrieved and compared. Results Mean heart dose (MHD) was 3.33 Gy with FB vs. 3.10 Gy with DIBH on normofractionated plans (p = 0.489), and 2.58 Gy with FB vs. 2.41 Gy with DIBH on hypofractionated plan (p = 0.489). The benefit of DIBH was not significant for any cardiac substructure. The most exposed cardiac substructure were the SAN (mean dose of 6.62 Gy for FB- and 5.64 Gy for DIBH-VMAT on normofractionated plans) and the RCA (mean dose of 4.21 Gy for FB- and 4.06 Gy for DIBH-VMAT on normofractionated plans). The maximum benefit was observed for the RCA with a median individual dose reduction of 0.84 Gy on normofractionated plans (p = 0.599). No significant dosimetric difference were observed for right lung. Liver mean dose was significantly lower with DIBH with median values decreasing from 2.54 Gy to 0.87 Gy (p = 0.01). Conclusion Adding DIBH to efficient cardiac-sparing radiotherapy techniques, such as VMAT, is not justified in the general case for locoregional R-BC irradiation. Specific R-BC patient subpopulations who could benefit from additional DIBH combination with locoregional VMAT are yet to be identified.

Journal

Acta Oncologica – Taylor & Francis

Published: Feb 1, 2023

Keywords: Breast cancer; VMAT; DIBH; cardiotoxicity

References

  • Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)
  • Heart toxicity from breast cancer radiotherapy : current findings, assessment, and prevention
  • Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy
  • The incidence and functional consequences of RT-associated cardiac perfusion defects
  • Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy
  • N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer
  • Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on Three-Dimensional dose distributions to cardiac substructures
  • Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer
  • Distribution of coronary artery stenosis after radiation for breast cancer
  • Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: a Case-Control study
  • Evaluating cardiac substructure exposure in breast rotational intensity modulated radiation therapy: effects of cancer laterality, fractionation and deep inspiration breath-hold
  • Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer
  • Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility
  • Cardiac substructure exposure in breast radiotherapy: a comparison between intensity modulated proton therapy and volumetric modulated arc therapy
  • Clinical practice of breast cancer protontherapy: a single-Centre experience from selection to treatment
  • Hadrontherapy techniques for breast cancer
  • Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses
  • Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients
  • Benefit of deep inspiratory breath hold for right breast cancer when regional lymph nodes are irradiated
  • Helical tomotherapy and volumetric modulated arc therapy: new therapeutic arms in the breast cancer radiotherapy
  • Assessment of a conventional volumetric-modulated arc therapy knowledge-based planning model applied to the new halcyon© O-ring linac in locoregional breast cancer radiotherapy
  • A radiotherapy contouring atlas for cardiac conduction node delineation
  • A cardiac contouring atlas for radiotherapy
  • Automatic treatment planning of VMAT for left-sided breast cancer with lymph nodes
  • Single arc volumetric modulated arc therapy of head and neck cancer
  • Radiotherapy-induced right ventricular remodelling: the missing piece of the puzzle
  • The arterial blood supply of the conducting system in normal human hearts
  • The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
  • Risk of ischemic heart disease in women after radiotherapy for breast cancer
  • Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: single Centre experience
  • The dose-response relationship for cardiovascular disease is not necessarily linear
  • The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial
  • Effects of radiation dose on liver after free-breathing volumetric modulated arc therapy for breast cancer
  • Identifying breast cancer patients who gain the most dosimetric benefit from deep inspiration breath hold radiotherapy
  • An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk
  • Should We move beyond mean heart dose?
  • Evaluation of a delineation software for cardiac atlas-based autosegmentation: an example of the use of artificial intelligence in modern radiotherapy
  • Development of simplified Auto-Segmentable functional cardiac atlas